Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Temporal and geographical external validation study and extension of the Mayo Clinic prediction model to predict eGFR in the younger population of Swiss ADPKD patients

Fig. 3

a Bland-Altman analysis of the observed eGFR versus the predicted eGFR derived from the model obtained from the development set with TKV as predictor. b Bland-Altman analysis observed eGFR vs. predicted eGFR derived from the model obtained from the development set with the five subclasses as predictor. c Bland-Altman analysis of the observed eGFR versus the predicted eGFR derived from the updated model 1 with two TKV measurements and d updated model 2 with time-varying TKV

Back to article page